Minapharm Pharmaceuticals (CAI:MIPH) Accounts Payable & Accrued Expense : E£1,309 Mil (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Accounts Payable & Accrued Expense?

Minapharm Pharmaceuticals's quarterly accounts payable & accrued expense increased from Dec. 2023 (E£909 Mil) to Jun. 2024 (E£1,197 Mil) and increased from Jun. 2024 (E£1,197 Mil) to Sep. 2024 (E£1,309 Mil).

Minapharm Pharmaceuticals's annual accounts payable & accrued expense increased from . 20 (E£0 Mil) to Dec. 2022 (E£981 Mil) but then declined from Dec. 2022 (E£981 Mil) to Dec. 2023 (E£909 Mil).

Minapharm Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Minapharm Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Accounts Payable & Accrued Expense Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Accounts Payable & Accrued Expense

980.52

908.98

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			-	-	908.98	1,196.92	1,308.70

Minapharm Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines